Factors determining penetrance in familial atypical haemolytic uraemic syndrome

被引:25
|
作者
Sansbury, Francis H. [1 ,2 ,3 ]
Cordell, Heather J. [4 ]
Bingham, Coralie [2 ,5 ]
Bromilow, Gilly [1 ]
Nicholls, Anthony [5 ]
Powell, Roy [6 ]
Shields, Bev [2 ]
Smyth, Lucy [5 ]
Warwicker, Paul [7 ]
Strain, Lisa [8 ]
Wilson, Valerie [8 ]
Goodship, Judith A. [4 ]
Goodship, Timothy H. J. [4 ]
Turnpenny, Peter D. [1 ,2 ]
机构
[1] Royal Devon & Exeter Hosp Heavitree, Royal Devon & Exeter NHS Fdn Trust, Peninsula Clin Genet Serv, Exeter, Devon, England
[2] Univ Exeter, Sch Med, Exeter, Devon, England
[3] St Michaels Hosp, Univ Hosp Bristol NHS Fdn Trust, Bristol Clin Genet Serv, Bristol, Avon, England
[4] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England
[5] Royal Devon & Exeter Hosp Wonford, Royal Devon & Exeter NHS Fdn Trust, Dept Renal Med, Exeter, Devon, England
[6] Royal Devon & Exeter Hosp Wonford, Royal Devon & Exeter NHS Fdn Trust, Res Design Serv South West, Exeter, Devon, England
[7] East & North Hertfordshire NHS Trust, Lister Renal Units, Stevenage, Herts, England
[8] Newcastle Upon Tyne Hosp NHS Fdn Trust, Northern Mol Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England
基金
英国医学研究理事会;
关键词
COMPLEMENT FACTOR-H; MULTILOCUS LINKAGE ANALYSIS; MEMBRANE COFACTOR PROTEIN; GENE-MUTATIONS; DISEASE; RECOGNITION; CFH; SUSCEPTIBILITY; PREDISPOSE; CANCER;
D O I
10.1136/jmedgenet-2014-102498
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Inherited abnormalities of complement are found in similar to 60% of patients with atypical haemolytic uraemic syndrome (aHUS). Such abnormalities are not fully penetrant. In this study, we have estimated the penetrance of the disease in three families with a CFH mutation (c.3643C>G; p. Arg1215Gly) in whom a common lineage is probable. 25 individuals have been affected with aHUS with three peaks of incidence-early childhood (n=6), early adulthood (n= 11) and late adulthood (n= 8). Eighteen individuals who have not developed aHUS carry the mutation. Methods We estimated penetrance at the ages of 4, 27, 60 and 70 years as both a binary and a survival trait using MLINK and Mendel. We genotyped susceptibility factors in CFH, CD46 and CFHR1 in affected and unaffected carriers. Results and Conclusions We found that the estimates of penetrance at the age of 4 years ranged from <0.01 to 0.10, at the age of 27 years from 0.16 to 0.29, at the age of 60 years from 0.39 to 0.51 and at the age of 70 years from 0.44 to 0.64. We found that the CFH haplotype on the allele not carrying the CFH mutation had a significant effect on disease penetrance. In this family, we did not find that the CD46 haplotypes had a significant effect on penetrance.
引用
收藏
页码:756 / 764
页数:9
相关论文
共 50 条
  • [1] Atypical haemolytic uraemic syndrome
    Kavanagh, David
    Goodship, Timothy H. J.
    Richards, Anna
    BRITISH MEDICAL BULLETIN, 2006, 77-78 : 5 - 22
  • [2] Interventions for atypical haemolytic uraemic syndrome
    Pugh, Dan
    O'Sullivan, Eoin D.
    Duthie, Fiona Ai
    Masson, Philip
    Kavanagh, David
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (03):
  • [3] Atypical haemolytic uraemic syndrome in a postpartum patient
    Hierholzer, Ashton
    Majdinasab, Elleana
    Young, Madeline
    Kauffman, Robert P.
    BMJ CASE REPORTS, 2023, 16 (11)
  • [4] Cardiovascular complications in atypical haemolytic uraemic syndrome
    Noris, Marina
    Remuzzi, Giuseppe
    NATURE REVIEWS NEPHROLOGY, 2014, 10 (03) : 174 - 180
  • [5] Cardiovascular complications in atypical haemolytic uraemic syndrome
    Marina Noris
    Giuseppe Remuzzi
    Nature Reviews Nephrology, 2014, 10 : 174 - 180
  • [6] A new model of atypical haemolytic uraemic syndrome
    Vernon, K. A.
    Malik, T.
    Botto, M.
    Pickering, M. C.
    MOLECULAR IMMUNOLOGY, 2011, 48 (14) : 1678 - 1678
  • [7] Podocyte dysfunction in atypical haemolytic uraemic syndrome
    Marina Noris
    Caterina Mele
    Giuseppe Remuzzi
    Nature Reviews Nephrology, 2015, 11 : 245 - 252
  • [8] Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
    Syed, Yahiya Y.
    DRUGS, 2021, 81 (05) : 587 - 594
  • [9] Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
    Yahiya Y. Syed
    Drugs, 2021, 81 : 587 - 594
  • [10] Eculizumab in secondary atypical haemolytic uraemic syndrome
    Cavero, Teresa
    Rabasco, Cristina
    Lopez, Antia
    Roman, Elena
    Avila, Ana
    Sevillano, Angel
    Huerta, Ana
    Rojas-Rivera, Jorge
    Fuentes, Carolina
    Blasco, Miquel
    Jarque, Ana
    Garcia, Alba
    Mendizabal, Santiago
    Gavela, Eva
    Macia, Manuel
    Quintana, Luis F.
    Maria Romera, Ana
    Borrego, Josefa
    Arjona, Emi
    Espinosa, Mario
    Portoles, Jose
    Gracia-Iguacel, Carolina
    Gonzalez-Parra, Emilio
    Aljama, Pedro
    Morales, Enrique
    Cao, Mercedes
    Rodriguez de Cordoba, Santiago
    Praga, Manuel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (03) : 466 - 474